Skip to content
News, Announcements and Expert Commentary from Inova

ICPH

Preparing for a Shortage of Cancer Doctors

John Deeken, MD, is president of the Inova Schar Cancer Institute. He is board-certified in medical oncology and specializes in head and neck cancers. Earlier this month, a study in the medical journal The Lancet Oncology predicted that cancer cases will rise worldwide in the next 2 decades. Meanwhile, we’ll face a shortage of cancer…

Read More

Inova Dedicates Inova Schar Cancer Institute alongside Patients, Cancer Survivors, Community Supporters and Elected Officials

New state-of-the-art cancer center emphasizes patient-centric mission, “Cancer. Care. We do both.” April 25, 2019, Fairfax, Virginia – On April 24, Inova Health System celebrated its place at the forefront of state-of-the-art cancer care and research with the dedication of the new flagship location of the Inova Schar Cancer Institute. The facility, a department of…

Read More

John Deeken, MD named President, Inova Schar Cancer Institute

FALLS CHURCH, VA– Inova, Northern Virginia’s largest non-profit healthcare provider, announces that John Deeken, MD, has been named President of Inova Schar Cancer Institute. He will also serve as Medical Director for the Inova Schar Head and Neck Cancer Program. The appointment coincides with the dedication of the Inova Schar Cancer Institute’s new flagship location…

Read More

Cancer Institute Grand Opening

Inova Schar Cancer Institute lobby.

Inova Schar Cancer Institute puts a full suite of cancer care services under one roof After years of planning and preparation, the new home of Inova Schar Cancer Institute is coming into focus. When it opens this spring, the 342,000-square-foot facility will provide the most complete cancer care in Northern Virginia. Inova already gives patients…

Read More

FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial

dart board with a red dart in the center bulls eye

Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…

Read More

Inova Discovery Series Attracts National Investors And Reveals New Consumer Health Findings, Biobuzz News, November 14, 2018

Inova Personalized Health Accelerator is hosted the Inova Discover Series event that brought together health tech companies together to discuss and showcase health tech innovation on November 7, 2018. BioBuzz wrote an article about the event and the impact IPHA has had not only on identifying and cultivating health innovations, but investing and adopting health tech innovations.…

Read More

New Software System Streamlines Authorizations to Speed Patient Care

CoverMyTest streamlines authorizations.

CoverMyTest automates workflow In the hopes of having better medical outcomes, more physicians and patients are asking for genetic and molecular diagnostic tests, creating more personalized treatments for patients. Unfortunately, it is also time-consuming and expensive. Many times, undergoing genetic testing requires prior authorization by a doctor, which is followed by a complicated matrix of…

Read More